EP 1001816 A4 20020717 - PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS
Title (en)
PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS
Title (de)
PERFLUORIETE ETHERN ZUSAMMENSETZUNGEN WIE KONTRASTMITTEL
Title (fr)
COMPOSITIONS D'ETHER PERFLUORE UTILISEES COMME AGENTS DE CONTRASTE DIAGNOSTIQUES
Publication
Application
Priority
- US 9719900 W 19971103
- US 3190396 P 19961125
- US 80099397 A 19970220
Abstract (en)
[origin: WO9823298A1] Compositions and methods for providing an image of an internal region of a patient. Embodiments of the invention involve vesicle compositions comprising, in an aqueous carrier, a perfluorinated ether compound and vesicles comprising one or more stabilizing compounds. The compositions may be administered to a patient, and the patient may be scanned using diagnostic imaging, such as ultrasound, to obtain a visible image of an internal region.
IPC 1-7
IPC 8 full level
A61K 49/22 (2006.01)
CPC (source: EP)
A61K 49/223 (2013.01)
Citation (search report)
- [X] WO 9631196 A1 19961010 - IMARX PHARMACEUTICAL CORP [US]
- [X] WO 9531965 A1 19951130 - MINNESOTA MINING & MFG [US]
- [PX] WO 9640281 A2 19961219 - ALLIANCE PHARMA [US], et al
- [E] WO 9842384 A1 19981001 - IMARX PHARMACEUTICAL CORP [US]
- [A] US 5350571 A 19940927 - KAUFMAN ROBERT J [US], et al
- [E] WO 9804292 A2 19980205 - ACUSPHERE INC [US]
- See references of WO 9823298A1
Designated contracting state (EPC)
DE FR GB IT
DOCDB simple family (publication)
WO 9823298 A1 19980604; AU 5161298 A 19980622; EP 1001816 A1 20000524; EP 1001816 A4 20020717
DOCDB simple family (application)
US 9719900 W 19971103; AU 5161298 A 19971103; EP 97946447 A 19971103